Hyderabad-based Celon Laboratories Limited today said the Phase I of its Rs 120 crore manufacturing facility coming up here had been completed.
The 11-acre unit is coming up at Kolthur village in the Genome Valley.
“We are yet to start the second phase of the unit and hope to complete the project in the next 18 months,” KV Ravinder, founder of Celon Labs, said.
The bio-pharmaceutical company has already registered 114 products, which have been launched in 17 markets. “Another 18 products are in the process of getting registered and 321 product files are under filing,” Ravinder said.
Celon Lab, which had raised Rs 70 crore from Sequoia Capital, has charted an aggressive growth plan in the international market by establishing local entities in south and central America, Asia-Pacific, Africa and CIS (Commonwealth of Independent State) countries.
Using in-house R&D and manufacturing capabilities, Celon Labs is focused on providing innovative formulations that offer quality and affordability to patients, a release said. The company registered revenues of Rs 100 crore last year. It has operations across 40 countries.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
